Beta blockers are go-to meds for many people who've survived a heart attack, but might not be needed for patients whose hearts have retained a normal pumping ability.

Commonly prescribed beta-blockers may increase the risk of depression for some patients who have had heart attacks, but also have a normal heart pumping ability, new research from Uppsala University suggests.

One study suggests these drugs could increase depression risk in heart attack survivors who retained normal heart pumping function, while providing no life-saving benefit.

In MI patients with preserved heart function, beta-blockers are linked to higher depressive symptoms, indicating a need for careful mental health assessment.

All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted earlier this year, this drug is unlikely to be needed for those heart patient

Common heart medications, like beta blockers, could have side effects including triggering depression in heart attack patients.

All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted earlier in 2024, this drug is unlikely to be needed for those heart patients who have normal pumping ability.

According to Leissner's team, that's especially true for folks who have survived a heart attack but whose cardiac pumping action has retained its efficacy. In a study published in April, the Swedish researchers found beta-blockers to be unnecessary for this type of patient.

Researchers show beta-blockers are unlikely to be needed for those heart patients who have a normal pumping ability. The drugs also increase the risk these patients will become depressed by the treatment.

All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted earlier this year, this drug is unlikely to be needed for those heart patients who have a normal pumping ability.